Citadel Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-285,886
| Closed | -$7.73M | – | 15558 |
|
|
2024
Q2 | $7.73M | Buy |
285,886
+162,346
| +131% | +$3.38M | ﹤0.01% | 3133 |
|
|
2024
Q1 | $2.26M | Sell |
123,540
-122,042
| -50% | -$1.94M | ﹤0.01% | 5281 |
|
|
2023
Q4 | $3.01M | Sell |
245,582
-372,525
| -60% | -$3.49M | ﹤0.01% | 4636 |
|
|
2023
Q3 | $9.27M | Buy |
618,107
+579,373
| +1,496% | +$12.1M | ﹤0.01% | 2782 |
|
|
2023
Q2 | $1.26M | Sell |
38,734
-524,803
| -93% | -$19.2M | ﹤0.01% | 5981 |
|
|
2023
Q1 | $22.1M | Buy |
563,537
+409,557
| +266% | +$20M | ﹤0.01% | 1824 |
|
|
2022
Q4 | $8.14M | Buy |
153,980
+145,470
| +1,709% | +$7.08M | ﹤0.01% | 3110 |
|
|
2022
Q3 | $383K | Sell |
8,510
-22,740
| -73% | -$978K | ﹤0.01% | 9050 |
|
|
2022
Q2 | $1.14M | Sell |
31,250
-175,070
| -85% | -$6.36M | ﹤0.01% | 6735 |
|
|
2022
Q1 | $8.52M | Buy |
206,320
+85,424
| +71% | +$3.01M | ﹤0.01% | 3227 |
|
|
2021
Q4 | $5.15M | Sell |
120,896
-28,348
| -19% | -$1.42M | ﹤0.01% | 4232 |
|
|
2021
Q3 | $8.21M | Buy |
149,244
+75,708
| +103% | +$3.96M | ﹤0.01% | 3416 |
|
|
2021
Q2 | $3.52M | Sell |
73,536
-2,799
| -4% | -$143K | ﹤0.01% | 5236 |
|
|
2021
Q1 | $3.87M | Buy |
76,335
+58,987
| +340% | +$3.28M | ﹤0.01% | 4848 |
|
|
2020
Q4 | $1.09M | Buy |
+17,348
| New | +$1.08M | ﹤0.01% | 6625 |
|
|
2020
Q3 | – | Sell |
-11,563
| Closed | -$631K | – | 10900 |
|
|
2020
Q2 | $485K | Sell |
11,563
-19,562
| -63% | -$751K | ﹤0.01% | 7132 |
|
|
2020
Q1 | $980K | Sell |
31,125
-5,866
| -16% | -$235K | ﹤0.01% | 5372 |
|
|
2019
Q4 | $1.49M | Buy |
+36,991
| New | +$1.3M | ﹤0.01% | 4884 |
|
|
2019
Q3 | – | Sell |
-36,017
| Closed | -$1.75M | – | 9878 |
|
|
2019
Q2 | $1.75M | Buy |
+36,017
| New | +$1.53M | ﹤0.01% | 4748 |
|
Other funds holding SILK
Citadel Advisors's SILK Position: Q3 2024 in Review
Citadel Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 285,886 shares — an estimated $7.73M sold.
Citadel Advisors first reported a position in SILK in Q2 2019 and held it in 19 quarters. The position peaked at $22.1M in Q1 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Citadel Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Citadel Advisors sold 285,886 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $7.73M.
- Citadel Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
- Citadel Advisors's Silk Road Medical, Inc. Common Stock position peaked at $22.1M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.